Yorktown Management & Research Company’s Amgen AMGN Stock Holding History

Yorktown Management & Research Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,450	Closed	-$342K	–	241
2020 Q2	$342K	Buy	+1,450	New	+$331K	0.31%	112
2019 Q2	–	Sell	-5,000	Closed	-$950K	–	299
2019 Q1	$950K	Hold	5,000	–	–	0.31%	83
2018 Q4	$973K	Sell	5,000 -1,700	-25%	-$332K	0.32%	81
2018 Q3	$1.39M	Hold	6,700	–	–	0.41%	64
2018 Q2	$1.24M	Buy	6,700 +5,000	+294%	+$884K	0.36%	75
2018 Q1	$290K	Hold	1,700	–	–	0.09%	282
2017 Q4	$296K	Buy	+1,700	New	+$301K	0.09%	292

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Yorktown Management & Research Company's AMGN Position: Q3 2020 in Review

Yorktown Management & Research Company sold out of Amgen (AMGN) in Q3 2020, closing a stake of 1,450 shares — an estimated $342K sold.

Yorktown Management & Research Company first reported a position in AMGN in Q4 2017 and held it in 7 quarters. The position peaked at $1.39M in Q3 2018. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

Yorktown Management & Research Company reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
Yorktown Management & Research Company sold 1,450 Amgen shares in Q3 2020, an estimated $342K.
Yorktown Management & Research Company first reported a position in Amgen in Q4 2017 and held it in 7 quarters.
Yorktown Management & Research Company's Amgen position peaked at $1.39M in Q3 2018.
2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Yorktown Management & Research Company's 13F filing for Q3 2020, filed 6 Nov 2020.